Investigating a small peptide for neurological diseases
NON-GLP DOSE-RANGE FINDING AND GLP TOXICITY STUDIES AND IN VITRO DRUG-DRUG INTERACTION STUDIES FOR A SMALL PEPTIDE
This study is working on creating new treatments for neurological diseases by helping researchers test a small peptide, which could lead to better options for patients like you in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Battelle Centers/pub Hlth Res & Evaluatn NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project ID | NIH-11212437 on NIH RePORTER |
What this research studies
This research focuses on developing biological therapeutics for neurological diseases by providing essential drug-development services to innovators in the field. It includes conducting dose-range finding, toxicity studies, and in vitro drug-drug interaction studies for a small peptide. The approach aims to support the advancement of candidate products to phase I clinical trials by offering expertise in assay development, pharmacokinetics, and toxicological studies. Patients may benefit from the development of new treatments that target neurological disorders.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals with neurological disorders who may be eligible for new biological therapies.
Not a fit: Patients with non-neurological conditions or those who do not meet the eligibility criteria for the new therapies may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic options for patients suffering from neurological diseases.
How similar studies have performed: Other research in the field of biological therapeutics for neurological diseases has shown promise, indicating that this approach could be effective.
Where this research is happening
Columbus, United States
- Battelle Centers/pub Hlth Res & Evaluatn — Columbus, United States (Active)
Researchers
- Principal investigator: Pang, Kaitlin — Battelle Centers/pub Hlth Res & Evaluatn
- Study coordinator: Pang, Kaitlin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.